Curelauncher targeting Big Pharma co's with ' for trials' service

Curelauncher is aiming to snag two more top-5 pharma companies as clients by the end of the year. If the Michigan-based company--which describes itself as " for clinical trials"--achieves its goal, it will have doubled the number of top-5 companies on its books, MedCity News reports. Article

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.